CN107242563A - A kind of fatigue resistant health food and preparation method thereof - Google Patents

A kind of fatigue resistant health food and preparation method thereof Download PDF

Info

Publication number
CN107242563A
CN107242563A CN201710253691.XA CN201710253691A CN107242563A CN 107242563 A CN107242563 A CN 107242563A CN 201710253691 A CN201710253691 A CN 201710253691A CN 107242563 A CN107242563 A CN 107242563A
Authority
CN
China
Prior art keywords
fatigue
health food
extract
mice
control group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710253691.XA
Other languages
Chinese (zh)
Inventor
范盘生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
One Hundred Reed (nanjing) Biological Technology Co Ltd
Original Assignee
One Hundred Reed (nanjing) Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by One Hundred Reed (nanjing) Biological Technology Co Ltd filed Critical One Hundred Reed (nanjing) Biological Technology Co Ltd
Priority to CN201710253691.XA priority Critical patent/CN107242563A/en
Publication of CN107242563A publication Critical patent/CN107242563A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention discloses a kind of fatigue resistant health food and preparation method thereof, by maca, ginseng, gumbo extract, sealwort, ginkgo biloba extract, tribulus terrestris extraction, cinnamomum cassia extract, citrulling, L arginine.It is made by pulverizing and sieving → premixing → pelletizing drying → whole grain → total mixed → tabletting → coating → inner packing → outsourcing → storage.Safety of the invention, non-toxic, orally available, oral or instant, the healthcare function for the sleep that is significantly improved.

Description

一种抗疲劳保健食品及其制备方法A kind of anti-fatigue health food and preparation method thereof

技术领域technical field

本发明属于保健品领域,具体的说,涉及一种抗疲劳保健食品及其制备方法。The invention belongs to the field of health products, and in particular relates to an anti-fatigue health food and a preparation method thereof.

背景技术Background technique

疲劳(fatigue)是一个涉及许多生理生化因素的综合性的生理过程,是人体脑力或体力活动到一定阶段时必然出现的一种正常的生理现象,它既标志着机体原有工作能力的暂时下降,又可能是机体发展到伤病状态的一个先兆。人们在研究疲劳时曾给它下过许多定义,1982年在第五届国际运动生化学术会议上,将疲劳定义为:机体生理过程不能持续其机能的特定水平上和/或不能维持预定的运动强度。Fatigue is a comprehensive physiological process involving many physiological and biochemical factors. It is a normal physiological phenomenon that must occur when the human body's mental or physical activities reach a certain stage. It not only marks the temporary decline of the original working ability of the body. , and may be a precursor to the development of the body to an injury state. People have given it many definitions when studying fatigue. In 1982, at the Fifth International Exercise Biochemistry Conference, fatigue was defined as: the body's physiological process cannot continue at a specific level of its function and/or cannot maintain a predetermined exercise strength.

疲劳是一种主观的不适感,主要表现为疲劳感、倦怠感,在进行长时间劳动、剧烈运动或长时间精神压力下会察觉到,这是一种正常的生理性保护反应,提示机体应该通过休息使机能恢复,从而避免对身体的进一步伤害。然而随着社会竞争的加剧,生活节奏的加快,使人们常常不顾疲劳,仍然选择长时间工作。长期处于疲劳状态,会损害人体的体力、体能,身体失衡,使人难以从事或完成某些消耗体力较大或动作细腻、精巧的工作,从而使工作效率下降;另一方面,长期疲劳还会使人皮肤松弛,面色无华,呈现出未老先衰的征兆;长期疲劳得不到恢复,使人体免疫系统功能失调,甚至造成免疫低下,机体抵抗 疾病的屏障被打破,使患者患病的几率增加。另外,长期心理压力、激素紊乱、免疫异常等,均是造成慢性疲劳综合征的主要诱因。超负荷的工作、过度的压力与不规律的生活作息使人们常常感觉到疲劳感、倦怠感长时间难以恢复,使人们长期处于亚健康状态,人群中约有70%的人处于这一状态,其中又以中老年人高发。Fatigue is a subjective sense of discomfort, mainly manifested as fatigue and burnout, which can be noticed during long-term labor, strenuous exercise or long-term mental stress. This is a normal physiological protective response, suggesting that the body should Rest to restore function and avoid further damage to the body. However, with the intensification of social competition and the acceleration of the pace of life, people often choose to work long hours regardless of fatigue. Being in a state of fatigue for a long time will damage the physical strength and fitness of the human body, and the body will be out of balance, making it difficult for people to engage in or complete some jobs that consume a lot of energy or have delicate and delicate movements, thereby reducing work efficiency; It makes people's skin loose and dull, showing signs of premature aging; long-term fatigue cannot be recovered, which makes the human immune system dysfunction, and even causes low immunity. Increase. In addition, long-term psychological stress, hormone disorders, and immune abnormalities are the main causes of chronic fatigue syndrome. Overload work, excessive pressure and irregular life schedule make people feel tired and burnout for a long time, which makes people in a sub-health state for a long time. About 70% of the people are in this state. Among them, middle-aged and elderly people have a high incidence.

大量的研究结果证实,疲劳可能发生在从大脑皮质到肌肉亚细胞结构这样一个广泛的区域。1980年Edwards提出了"神经-肌肉疲劳链"的概念,链中任何一个环节受到破坏或有中断,都会造成肌肉力量下降和输出功率降低。根据疲劳链中疲劳发生的部位,可以分为中枢疲劳和外用疲劳两大部分。中枢疲劳是指从大脑皮层→脊髓→外围神经这段区域发生的疲劳;外围疲劳指的是神经-肌肉接点以下各环节发生的疲劳。A large number of research results confirm that fatigue may occur in such a wide range of regions from the cerebral cortex to the muscle subcellular structure. In 1980, Edwards proposed the concept of "nervous-muscular fatigue chain". Any link in the chain that is damaged or interrupted will cause a decrease in muscle strength and output power. According to the location of fatigue in the fatigue chain, it can be divided into two parts: central fatigue and external fatigue. Central fatigue refers to the fatigue that occurs in the area from the cerebral cortex→spinal cord→peripheral nerves; peripheral fatigue refers to the fatigue that occurs in the links below the nerve-muscle junction.

基于此,需要找到抗疲劳物质来延缓长时间劳动、剧烈运动或过度精神压力下造成的疲劳发生,或使疲劳状态尽快恢复到正常状态,以期使人们亚健康状态恢复正常或对疲劳综合征产生疗效。现有的抗疲劳保健食品主要以中药为主,特点是注重养生,消费者需长期服用,起效慢。Based on this, it is necessary to find anti-fatigue substances to delay the occurrence of fatigue caused by long-term labor, strenuous exercise or excessive mental stress, or to restore the fatigue state to a normal state as soon as possible, in order to restore people's sub-health state to normal or treat fatigue syndrome. curative effect. The existing anti-fatigue health food is mainly based on traditional Chinese medicine, which is characterized by focusing on health preservation. Consumers need to take it for a long time, and the onset of effect is slow.

因此,提供一种新的抗疲劳产品具有现实意义。Therefore, it is of practical significance to provide a new anti-fatigue product.

发明内容Contents of the invention

为解决以上技术问题,本发明的目的之一在于提供一种抗疲劳、纠正亚健康状态的保健品。In order to solve the above technical problems, one of the objectives of the present invention is to provide a health product for anti-fatigue and correction of sub-health state.

本发明的目的之二在于提供一种抗疲劳、纠正亚健康状态的保健品制备方法。The second object of the present invention is to provide a preparation method of a health product for anti-fatigue and correction of sub-health state.

本发明目的之一是这样实现的:One of purpose of the present invention is achieved like this:

一种抗疲劳保健食品,按重量份数包含以下组分:An anti-fatigue health food, comprising the following components in parts by weight:

上述保健食品还添加有药用辅料。The above-mentioned health food is also added with pharmaceutical excipients.

上述保健食品为口服液、饮料、片剂、胶囊、喷雾剂或透皮吸收剂。本保健食品的给药方式为口服或外用。所述本保健食品的服用方式为每日1~2次,每次100-2000mg/kg体重。The health food mentioned above is oral liquid, drink, tablet, capsule, spray or transdermal absorber. The way of administration of this health food is oral or external application. The health food is taken 1-2 times a day, 100-2000 mg/kg body weight each time.

本发明目的之二是这样实现的:Two of the object of the present invention is achieved in this way:

一种抗疲劳保健食品的制备方法,按如下步骤进行:原辅料粉碎过筛→预混→制粒干燥→整粒→总混→压片→包衣→内包装→外包→入库。A preparation method of an anti-fatigue health food, which is carried out in the following steps: crushing and screening of raw and auxiliary materials → premixing → granulation and drying → granulation → total mixing → tabletting → coating → inner packaging → outsourcing → storage.

本保健食品应用于纠正纠正亚健康状态或治疗慢性疲劳综合症;所述纠正亚健康状态为增加肝糖原含量、减少全血乳酸含量或降低血浆尿素氮含量。The health food is used for correcting sub-health state or treating chronic fatigue syndrome; said sub-health state correction is increasing liver glycogen content, reducing whole blood lactic acid content or reducing plasma urea nitrogen content.

以下为本保健品的主要成分。The following are the main ingredients of this health product.

L-精氨酸(Arginine)L-arginine (Arginine)

精氨酸是一种含有两个碱性基团及氨基和胍基的氨基酸.在生理pH条件下,属碱性氨基酸(PH 10.5~12.0),分子式为C6H14N4O2,分子量174.20,熔点:223~224℃,白色菱形结晶(从水中析出,含2分子结晶水)或单斜片状结晶(无结晶水),无臭,味苦;易溶于水(0℃水中溶解度为83g/L,50℃水中溶解度为400g/L),极微溶于乙醇,不溶于乙醚.在自然界中有两种异构体存在:D-精氨酸和L-精氨酸,动物体内具有重要的营养生理作用的是L-精氨酸.Arginine is an amino acid containing two basic groups, an amino group and a guanidine group. Under physiological pH conditions, it is a basic amino acid (PH 10.5-12.0), with a molecular formula of C6H14N4O2, a molecular weight of 174.20, and a melting point of 223-224 ℃, white diamond-shaped crystals (precipitated from water, containing 2 molecules of crystal water) or monoclinic flaky crystals (no crystal water), odorless, bitter taste; easily soluble in water (0 ℃ water solubility is 83g/L, 50 ℃ Solubility in water is 400g/L), very slightly soluble in ethanol, insoluble in ether. There are two isomers in nature: D-arginine and L-arginine, which have important nutritional and physiological functions in animals It's L-arginine.

L-精氨酸是合成蛋白质和肌酸的重要原料,是人和动物体内的半必需氨基酸精氨酸具有重要的生理、代谢和营养作用,几乎机体中所有组织均利用Arg合成细胞浆蛋白和核蛋白.精氨酸在促进肌肉内蛋白质合成,增强机体的免疫力,细胞分裂,伤口复原和分泌激素等各种生理过程中,也都担任着重要的角色精氨酸也是体内合成NO的前提物质,而体内NO合成的增加,对于平衡血液,增强血流,改善心脑供血,增强血管弹性,恢复血管功能效果明显。是最强的血管舒张因子,具有抗粥样动脉硬化、调节血压的功能,精氨酸的多种生物学功能引起了营养和医学科研工作者的广泛关注,从而成为目前氨基酸研究的热点之一.L-arginine is an important raw material for the synthesis of protein and creatine, and is a semi-essential amino acid in humans and animals. Arginine has important physiological, metabolic and nutritional functions. Almost all tissues in the body use Arg to synthesize cytoplasmic proteins and creatine. Nucleoprotein. Arginine also plays an important role in various physiological processes such as promoting protein synthesis in muscle, enhancing the body's immunity, cell division, wound recovery and secretion of hormones. Arginine is also a prerequisite for the synthesis of NO in the body. The increase of NO synthesis in the body has obvious effects on balancing blood, enhancing blood flow, improving heart and brain blood supply, enhancing blood vessel elasticity, and restoring blood vessel function. It is the strongest vasodilation factor, has the functions of anti-atherosclerosis and regulating blood pressure. The various biological functions of arginine have attracted widespread attention of nutrition and medical researchers, and thus become one of the hot spots of amino acid research. .

瓜氨酸Citrulline

最新发现西瓜中含有一项重要的有益成分----瓜氨酸。氨基酸是构成蛋白质的基本单位,瓜氨酸是氨基酸的一种。西瓜中瓜氨酸的含量比任何食物都高,人们最早是从西瓜中提取瓜氨酸,瓜氨酸由此得名。The latest discovery is that watermelon contains an important beneficial ingredient - citrulline. Amino acid is the basic unit of protein, and citrulline is a kind of amino acid. The content of citrulline in watermelon is higher than that of any food. People first extracted citrulline from watermelon, hence the name citrulline.

瓜氨酸是从鸟氨酸及氨基甲酰磷酸盐在尿素循环中生成,或是通过一氧化氮合酶(NOS)催化精氨酸生成NO的副产物。首先,精氨酸会被氧化为N-羟基-精氨酸,再行氧化成瓜氨酸并释出一氧化氮。Citrulline is produced in the urea cycle from ornithine and carbamoyl phosphate, or as a by-product of NO from arginine catalyzed by nitric oxide synthase (NOS). First, arginine is oxidized to N-hydroxy-arginine, which is oxidized to citrulline and releases nitric oxide.

适量的瓜氨酸和各种维生素可以促进增加能量,并维持免疫系统。瓜氨酸帮助身体恢复疲劳和压力,还可以维持身体酸碱度平衡。Moderate amounts of citrulline and various vitamins promote increased energy and maintain the immune system. Citrulline helps the body recover from fatigue and stress, and also maintains the body's pH balance.

提高建康的运动功能,瓜氨酸可在人体内与氨作用,生成精氨酸和一氧化氮。一氧化氮能活化酵素,导致平滑肌舒张。它也可以使人的血管获得松弛,用于增强机能,有助于生育功能。To improve Jiankang's motor function, citrulline can react with ammonia in the human body to generate arginine and nitric oxide. Nitric oxide activates enzymes that lead to smooth muscle relaxation. It can also relax the blood vessels of the person, which is used to enhance the function and help the reproductive function.

人参(Panax ginseng)Ginseng (Panax ginseng)

人参,又称为亚洲参,在中国东北土名“棒槌”,是具有肉质的根,可药用。人参属于五加科,主要生长在东亚,特别是寒冷地区。人参是亚洲常见药材,北中美洲也普遍使用花旗参。Ginseng, also known as Asian ginseng, is called "bangchui" in Northeast China. It is a fleshy root that can be used medicinally. Ginseng belongs to the Araliaceae family and grows mainly in East Asia, especially in cold regions. Ginseng is a common medicinal herb in Asia, and American ginseng is also commonly used in North and Central America.

人参之所以很稀奇,很名贵,主要与它的药用价值有关。在很早的医书《神农本草经》中就认为,人参有“补五脏、安精神、定魂魄、止惊悸、除邪气、明日开心益智”的功效,“久服轻身延年”。李时珍在《本草纲目》中也对人参极为推崇,认为它能"治男妇一切虚症"。The reason why ginseng is very rare and expensive is mainly related to its medicinal value. In the very early medical book "Shen Nong's Materia Medica", it is believed that ginseng has the effects of "replenishing the five internal organs, calming the spirit, calming the soul, relieving panic, eliminating evil spirits, making tomorrow happy and improving intelligence", and "long-term use can make life easier and prolong life". Li Shizhen also highly praised ginseng in "Compendium of Materia Medica", thinking that it can "cure all deficiencies in men and women".

人参可以分离出30余种人参皂甙,另外,人参还含有多种有机酸及酯类、各种维生素、甾醇、酶和20多种微量元素。More than 30 kinds of ginsenosides can be isolated from ginseng. In addition, ginseng also contains a variety of organic acids and esters, various vitamins, sterols, enzymes and more than 20 trace elements.

日常生活中,人参及其制备常常用于愈后恢复、增强体力、调节荷尔蒙、降低血糖和控制血压、控制肝指数和肝功能保健等。In daily life, ginseng and its preparation are often used for post-healing recovery, enhancing physical strength, regulating hormones, lowering blood sugar and controlling blood pressure, controlling liver index and liver function health care, etc.

银杏(Ginkgo biloba L.)Ginkgo biloba L.

银杏是一种具有很高药用价值的植物,银杏树是我国古老的树种,它是神奇的医疗之树,2亿5千多年前侏罗纪恐龙掌控地球时,银杏已经是最繁盛的植物之一。地球生命历经千亿年的变动,尤其是第四世纪冰川覆盖之后,只有银杏仍保持它最原始的面貌,在生物演化学史上被称为“活化石”。其叶、果 实、种子均有较高的药用价值,其药理作用不断被认识,临床应用范围逐步扩大。Ginkgo is a plant with high medicinal value. The Ginkgo tree is an ancient tree species in my country. It is a magical tree of medicine. When the Jurassic dinosaurs took control of the earth more than 250 million years ago, Ginkgo was already the most prosperous one of the plants. Life on earth has gone through hundreds of billions of years of changes, especially after being covered by glaciers in the fourth century, only ginkgo still maintains its most primitive appearance, and is called a "living fossil" in the history of biological evolution. Its leaves, fruits, and seeds all have high medicinal value, its pharmacological effects are constantly being recognized, and the scope of clinical application is gradually expanding.

近年来中国科学院和国内外众多医学专家研究发现:银杏叶中可提取160多种有效的药用成分.其中,黄酮类化合物35种;17种氨基酸和多种微量元素.In recent years, the Chinese Academy of Sciences and many medical experts at home and abroad have found that more than 160 effective medicinal ingredients can be extracted from Ginkgo biloba leaves. Among them, there are 35 kinds of flavonoids; 17 kinds of amino acids and various trace elements.

银杏具有抗衰老,提高机体免疫力,增强人体抵抗力等多种功能。Ginkgo biloba has many functions such as anti-aging, improving the body's immunity, and enhancing the body's resistance.

肉桂(Cortex Cinnamomi Cassiae)Cinnamon (Cortex Cinnamomi Cassiae)

肉桂为樟科植物肉桂和大叶清化桂的干皮和枝皮。肉桂常绿乔木,生于常绿阔叶林中,但多为栽培。我国福建、台湾、广东、广西、云南等地的热带及亚热带地区均有栽培,尤以广西栽培为多,大多为人工纯林。Cinnamon is the dry bark and branch bark of Cinnamon and Daye Qinghua Gui of Lauraceae. Cinnamon is an evergreen tree, born in evergreen broad-leaved forests, but mostly cultivated. It is cultivated in tropical and subtropical regions in Fujian, Taiwan, Guangdong, Guangxi, Yunnan and other places in China, especially in Guangxi, where most of them are artificial pure forests.

肉桂的功效与作用,肉桂味辛甘、性热,入肾、脾、膀胱经;有补元阳,暖脾胃,除积冷,通脉止痛和止泻的功效;主治命门火衰、肢冷脉微、亡阳虚脱、腹痛泄泻、寒疝、腰膝冷痛、阴疽流注、虚阳浮越之上热下寒等症。Efficacy and function of cinnamon, cinnamon is spicy and sweet, hot in nature, and enters the kidney, spleen, and bladder meridian; Mild cold pulse, yang collapse, abdominal pain and diarrhea, cold colic, cold pain in the waist and knees, bleeding from the yin and gangrene, deficiency of yang floating above the heat and below the cold, etc.

黄精(Polygonatum sibiricum Delar.ex Redonte)Polygonatum sibiricum Delar.ex Redonte

黄精是百合科植物黄精、多花黄精和滇黄精的根茎,属于补益类传统延缓衰老保健食品。本品味甘性平无毒,归肺脾肾三经,功能滋阴润肺、补脾益气、滋肾填精。Polygonatum Polygonatum is the rhizome of Polygonatum Polygonatum, Polygonatum Polyflora and Polygonatum Dianensis of Liliaceae. It belongs to the tonic traditional anti-aging health food. This taste is sweet, flat and non-toxic, and it belongs to the three meridians of the lung, spleen and kidney.

黄精含有多种甾体皂、黄精多糖、洋地黄糖以及少量葱敍类化合物等,具有延长家蚕生存期、对抗自由基损伤、增强免疫功能,调节第二信使环磷酸腺(cAMP)水平、增强心肌收缩力、增强冠状动脉血流量、降血糖、降血脂、抗菌、抗病毒、抗幅射、抗突变、抗疲劳等作用。是一种有很好开发前景的中药。Polygonatum contains a variety of steroidal soaps, Polygonatum polysaccharides, digitalis sugar and a small amount of onion-like compounds, etc., which can prolong the survival period of silkworms, resist free radical damage, enhance immune function, regulate the level of the second messenger cyclic adenophosphate (cAMP), enhance Myocardial contractility, enhanced coronary blood flow, hypoglycemic, hypolipidemic, antibacterial, antiviral, antiradiation, antimutagenic, antifatigue, etc. It is a traditional Chinese medicine with good development prospects.

刺蒺藜(Tribulus terrestris L.)Tribulus terrestris L.

为蒺藜科一年或多年生草本植物蒺藜的果实,主要产于东北、华北、及西北等地。刺蒺藜含脂肪油、挥发油、鞣质、树脂、甾醇、钾盐、微量生物碱、皂甙等。其水提物、乙醇浸出液对麻醉动物均有降压作用;蒺藜茎叶粗皂甙对小鼠遭受高温、低温、缺氧及游泳应激刺激均有明显保护作用:并能显着降低大鼠肾上腺内维生素C(Vc)含量,也能抑制大剂量氢化可的松引起的耗竭现象发生,对ACTH引起的Vc含量下降起保护作用。切除小鼠双侧肾上腺后,其耐缺氧作用不再复现。这些作用可能与肾上腺皮质有关,调节其功能免遭耗竭可能是实现强壮的途径之一。Tribesta(蒺藜地上部分制成的制剂)给予雄性大鼠口服可明显刺激精子形成,兴奋赛托利细胞(Sertolicell)活性,增加性欲;给予雌性大鼠则能促进发情,提高生殖力。It is the fruit of Tribulus terrestris, an annual or perennial herb of the family Tribulus, mainly produced in Northeast China, North China, and Northwest China. Tribulus terrestris contains fatty oil, volatile oil, tannin, resin, sterol, potassium salt, trace alkaloid, saponin, etc. Its water extract and ethanol extract have antihypertensive effects on anesthetized animals; saponins from stems and leaves of Tribulus terrestris have obvious protective effects on mice subjected to high temperature, low temperature, hypoxia and swimming stress; Vitamin C (Vc) content in the body can also inhibit the depletion phenomenon caused by high-dose hydrocortisone, and play a protective role in the decline of Vc content caused by ACTH. After the removal of bilateral adrenal glands in mice, the hypoxia tolerance effect was no longer reproduced. These effects may be related to the adrenal cortex, and regulating its function from exhaustion may be one of the ways to achieve strength. Oral administration of Tribesta (a preparation made from the aerial parts of Tribulus terrestris) to male rats can significantly stimulate sperm formation, stimulate the activity of Sertolicell cells (Sertolicell), and increase libido; administration to female rats can promote estrus and improve fertility.

秋葵(Hibiscus esculentus L.)Okra (Hibiscus esculentus L.)

秋葵的别名有咖啡黄葵、黄秋葵、毛茄等。原产于非洲,20世纪初由印度引入我国。它的可食用部分是果荚,脆嫩多汁,滑润不腻,香味独特,深受人们青睐。The aliases of okra include coffee yellow sunflower, yellow okra, hair eggplant and so on. Originated in Africa, it was introduced into my country from India in the early 20th century. Its edible part is the fruit pod, which is crisp, tender and juicy, smooth and not greasy, and has a unique fragrance, which is very popular among people.

秋葵嫩果中含有一种黏性液质及阿拉伯聚糖、半乳聚糖、鼠李聚糖、蛋白质等,经常食用帮助消化、增强体力、保护肝脏、健胃整肠。秋葵含有铁、钙及糖类等多种营养成分,有预防贫血的效果。秋葵含有维生素A和β—胡萝卜素等,有益于视网膜健康、维护视力;其中富含有锌和硒等微量元素,能增强人体防癌、抗癌。秋葵中的黏蛋白有抑制糖吸收的作用,所以近年来又作为治疗糖尿病的偏方。秋葵还含有特殊的具有药效的成分,能强肾补虚,对男性器质性疾病有辅助治疗作用,享有“植物伟哥”之美誉。The tender okra fruit contains a viscous liquid, arabinan, galactan, rhamnolan, protein, etc. It is often eaten to help digestion, enhance physical strength, protect the liver, and strengthen the stomach and intestines. Okra contains various nutrients such as iron, calcium and sugar, and has the effect of preventing anemia. Okra contains vitamin A and β-carotene, which are beneficial to the health of the retina and maintain vision; it is rich in trace elements such as zinc and selenium, which can enhance the body's anti-cancer and anti-cancer. The mucin in okra can inhibit the absorption of sugar, so it has been used as a folk prescription for treating diabetes in recent years. Okra also contains special medicinal ingredients, which can strengthen the kidney and tonify deficiency, and have an auxiliary therapeutic effect on male organic diseases. It enjoys the reputation of "plant Viagra".

玛咖(Maca)Maca

玛咖(Lepidium meyemii Walp),是十字花科独行菜属一年生或两年生草本植物,原产秘鲁中部海拔4000m以上的安第斯山区。由于Maca耐低温、大风,能在恶劣的生态条件下生长,成为当地主要作物之一。主要食用部位是根,地下膨大的贮藏根直径2~5cm,表面颜色大多为黄色或紫色,肉质白色或淡黄色,具有刺激性气味和特殊的咸味奶油糖果气味。目前,玛咖的高产地(栽培品为主)仍在安第斯山脉卡华玛沃地区(Carhuamayo)和胡宁区(Junin)。引种至秘鲁其他地区或国外德国、捷克等地的情况不佳,发育不良未获得满意的结果。玛咖适宜生长地为海拔4000~4500m的高寒、强风及高日照地区。Maca (Lepidium meyemii Walp) is an annual or biennial herb of the genus Brassicaceae. It is native to the Andes in central Peru at an altitude of 4000m or more. Because Maca is resistant to low temperature and strong wind, it can grow under harsh ecological conditions and has become one of the main local crops. The main edible part is the root. The diameter of the underground enlarged storage root is 2-5cm. The surface color is mostly yellow or purple, and the flesh is white or light yellow. It has a pungent smell and a special salty butterscotch smell. At present, the high-yield areas of maca (mainly cultivated products) are still in the Carhuamayo and Junin regions of the Andes. The situation of introduction to other regions of Peru or foreign countries such as Germany and the Czech Republic is not good, and satisfactory results have not been obtained due to dysplasia. Maca is suitable for growing in areas with an altitude of 4000-4500m in high cold, strong wind and high sunshine.

玛咖(Maca)是药食兼用的植物,特产于南美洲秘鲁,当地印加人将其用做,补药,称其为秘鲁人参。在南美秘鲁等地,玛咖根鲜用时可与肉或其它蔬菜一起炒熟食用,晒干后则用水或牛奶煮熟即可食用,数千年来,玛咖根作为食物和草药用于增强精力,抗疲劳,改善性功能,提高生育力,治疗女性更年期综合征等。Maca (Maca) is a plant that can be used both as medicine and food. It is specially produced in Peru, South America. The local Incas used it as a tonic and called it Peruvian ginseng. In places such as Peru in South America, maca root can be eaten fresh and fried with meat or other vegetables, and cooked in water or milk after drying. For thousands of years, maca root has been used as food and herbal medicine to enhance Energy, anti-fatigue, improve sexual function, increase fertility, treat menopausal syndrome in women, etc.

实验experiment

负重游泳是评价机体运动性疲劳的重要指标,游泳时间的长短可以反映动物运动疲劳的程度。体内储备的糖原是小鼠运动的主要能量来源,机体剧烈运动需要消耗大量糖原,因此糖原储备也是评价机体抗疲劳的一个重要指标。乳酸在机体供能体系中占有重要的地位,它是糖酵解供能的最终产物,又是有氧代谢供能系统中的重要氧代谢基质,并且乳酸可在肝脏内通过糖的异生作用转变为葡萄糖供能。但是如果机体内产生过量的乳酸.会使肌肉中H+浓度上升.pH下降,进而引起一系列生化变化,就会引起疲劳。研究显示,尿素氮(BUN)的增加与机体对负荷适应能力呈负相关,机体BUN含量随运动负荷的增加而增加, 所以BUN是较为理想、灵敏的疲劳指标。Weight-bearing swimming is an important index to evaluate the body's exercise fatigue, and the length of swimming time can reflect the degree of animal exercise fatigue. Glycogen stored in the body is the main energy source for mice to exercise, and the body needs to consume a large amount of glycogen during strenuous exercise, so glycogen storage is also an important indicator for evaluating the body's resistance to fatigue. Lactic acid plays an important role in the energy supply system of the body. It is the final product of glycolysis energy supply and an important oxygen metabolism substrate in the aerobic metabolism energy supply system, and lactic acid can be used in the liver through glucose neogenesis converted to glucose for energy. However, if excessive lactic acid is produced in the body, the H+ concentration in the muscle will increase and the pH will decrease, which will cause a series of biochemical changes, which will cause fatigue. Studies have shown that the increase of urea nitrogen (BUN) is negatively correlated with the body's ability to adapt to load, and the body's BUN content increases with the increase of exercise load, so BUN is an ideal and sensitive fatigue indicator.

1材料与方法1 Materials and methods

1.1样品:1.1 Sample:

1.2实验动物:五月龄中年雄性ICR小鼠;八月龄老年雄性C57小鼠。1.2 Experimental animals: five-month-old middle-aged male ICR mice; eight-month-old old male C57 mice.

1.3仪器与试剂:游泳箱、铅丝、全波长酶标仪、恒温水浴箱、离心机、肝糖原检测试剂盒(南京建成,货号A043)、乳酸检测试剂盒(南京建成,货号A019-1)、尿素氮试剂盒(南京建成,货号C013-1)。1.3 Instruments and reagents: swimming box, lead wire, full-wavelength microplate reader, constant temperature water bath, centrifuge, liver glycogen detection kit (Nanjing Jiancheng, product number A043), lactic acid detection kit (Nanjing Jiancheng, product number A019-1) , Burea Nitrogen Kit (Nanjing Jiancheng, Item No. C013-1).

1.4实验方法:1.4 Experimental method:

A.第一批:将60只雄性五月龄中年ICR小鼠随机分为4组,每组15只。小剂量组腹腔注射给药400mg/kg的药品,中剂量腹腔注射给药800mg/kg的药品,大剂量腹腔注射给药1600mg/kg的药品。对照组组给予同体积的生理盐水。于每天上午10:00至11:00给药一次,连续给药7天。A. The first batch: 60 male five-month-old middle-aged ICR mice were randomly divided into 4 groups, 15 in each group. The low-dose group received 400 mg/kg of drugs by intraperitoneal injection, the middle-dose group received 800 mg/kg of drugs by intraperitoneal injection, and the high-dose group received 1600 mg/kg of drugs by intraperitoneal injection. The control group was given the same volume of normal saline. Administer once a day from 10:00 am to 11:00 am for 7 consecutive days.

B.第二批:将100只雄性八月龄老年C57小鼠随机分为4组,每组20只。小剂量组灌胃400mg/kg的药品,中剂量灌胃800mg/kg的药品,大剂量灌1600mg/kg的药品。对照组给予同体积的水。于每天上午10:00至11:00给药一次,连续给药7天。B. The second batch: 100 male eight-month old C57 mice were randomly divided into 4 groups, 20 in each group. The medicine of 400mg/kg was administered orally in the small dose group, the medicine of 800mg/kg was administered orally in the middle dose, and the medicine of 1600mg/kg was administered in large dose. The control group was given the same volume of water. Administer once a day from 10:00 am to 11:00 am for 7 consecutive days.

C.第三批:将80只雄性五月龄中年ICR小鼠随机分为4组,每组20只。对照组正常环境下饲养14天,其余三组进行慢性疲劳综合症造模:每天上午9:00至11:00进行束缚,每次一小时,每天下午将小鼠放入水深为35cm,水温为21±1℃的游泳箱内强制游泳1小时,连续造模14天。从第15天开始给药,小剂量灌胃400mg/kg的药品,大剂量灌胃1600mg/kg的药品。对照组组给予同体积的水。于每天上午10:00至11:00给药一次,连续给药7天。C. The third batch: 80 male five-month-old middle-aged ICR mice were randomly divided into 4 groups, 20 in each group. The control group was fed for 14 days under normal conditions, and the remaining three groups were subjected to chronic fatigue syndrome modeling: they were restrained from 9:00 am to 11:00 am every day for one hour each time, and the mice were put into water at a depth of 35 cm and a water temperature of Compulsory swimming in a swimming box at 21±1°C for 1 hour, and continuous modeling for 14 days. Begin to administer from the 15th day, the medicine of 400mg/kg is gavaged by stomach in a small dose, and the medicine of 1600mg/kg is gavaged by a large dose. The control group was given the same volume of water. Administer once a day from 10:00 am to 11:00 am for 7 consecutive days.

1.4.1负重游泳实验1.4.1 Weight-bearing swimming test

末次给予保健食品30min后,给小鼠尾部负其体重的4%质量的铅丝。将小鼠放入水深为35cm,水温为21±1℃的游泳箱内游泳,直到力竭。力竭的判定标准为小鼠头部沉入水中10s内不浮出水面,记录力竭时间。30 minutes after the last administration of health food, a lead wire with a weight of 4% of its body weight was given to the tail of the mice. The mice were put into a swimming box with a water depth of 35cm and a water temperature of 21±1°C to swim until exhausted. The criterion for judging exhaustion was that the head of the mouse did not surface within 10 seconds after being submerged in the water, and the exhaustion time was recorded.

1.4.2肝糖原测定1.4.2 Determination of liver glycogen

小鼠负重游泳后,休息10分钟,在摘眼球采血后将小鼠处死。取出肝脏,用生理盐水漂洗后再用滤纸吸干,精确称取50mg肝脏。按照试剂盒说明书进行肝脏肝糖原的测定。After swimming with weight, the mice rested for 10 minutes, and the mice were sacrificed after the eyeballs were removed for blood collection. The liver was taken out, rinsed with normal saline and blotted dry with filter paper, and 50 mg of the liver was accurately weighed. Hepatic glycogen was measured according to the kit instructions.

1.4.3全血乳酸测定1.4.3 Determination of lactic acid in whole blood

小鼠负重游泳后,休息10分钟,摘除眼球取血,按照试剂盒说明进行全血乳酸的测定。After swimming with weight, the mice rested for 10 minutes, their eyeballs were removed, blood was collected, and whole blood lactic acid was measured according to the kit instructions.

1.4.4血浆指标测定1.4.4 Determination of plasma indicators

小鼠负重游泳后,休息10分钟,眼球采血,用EDTA钠盐抗凝后3500转离心10分钟后分离出血浆,按照试剂盒说明书进行血浆尿素氮的测定。After swimming with weight, the mice rested for 10 minutes, blood was collected from the eyeballs, anticoagulated with EDTA sodium salt, centrifuged at 3500 rpm for 10 minutes, and the plasma was separated, and the plasma urea nitrogen was measured according to the kit instructions.

2结果2 results

2.1小鼠负重游泳时间测定2.1 Determination of weight-bearing swimming time of mice

图1A、图1B、图1C表示抗疲劳保健食品对小鼠负重游泳时间的影响。其中图1A为第一批腹腔注射实验结果;图1B为第二批口服实验结果,*表示p<0.05。与对照组比较,C为第三批口服抗慢性疲劳综合症实验结果。由图1A可以看出,腹腔注射给予本保健食品具有延长小鼠负重游泳时间的趋势,且此趋势呈剂量依赖性;由图1B可以看出,与对照组相比,口服给予本保健食品后小鼠负重游泳时间呈现剂量依赖性延长,经方差分析,中、大剂量组与对照组相比有显著 性差异(p<0.05)。由图1C可以看出,与对照组相比,模型组的小鼠负重游泳时间明显下降,而口服给予本保健食品后小鼠负重游泳时间与模型组相比有明显延长。Figure 1A, Figure 1B, and Figure 1C show the effects of anti-fatigue health food on the weight-bearing swimming time of mice. Figure 1A shows the results of the first batch of intraperitoneal injection experiments; Figure 1B shows the results of the second batch of oral experiments, * indicates p<0.05. Compared with the control group, C is the result of the third batch of oral anti-chronic fatigue syndrome experiments. It can be seen from Figure 1A that intraperitoneal injection of this health food has a tendency to prolong the weight-bearing swimming time of mice, and this trend is dose-dependent; it can be seen from Figure 1B that compared with the control group, after oral administration of this health food The weight-bearing swimming time of the mice was prolonged in a dose-dependent manner, and the analysis of variance showed that there was a significant difference between the medium and high dose groups and the control group (p<0.05). It can be seen from Figure 1C that compared with the control group, the weight-bearing swimming time of the mice in the model group was significantly reduced, and the weight-bearing swimming time of the mice after oral administration of the health food was significantly prolonged compared with the model group.

2.2小鼠肝糖原测定2.2 Determination of mouse liver glycogen

图2A、图2B、图2C、表示抗疲劳保健食品对小鼠肝糖原储备的影响,其中图2A为第一批腹腔注射实验结果,*表示p<0.05,与对照组比较;图2B为第二批口服实验结果,*表示p<0.05,与对照组比较;图2C为第三批口服抗慢性疲劳综合症实验结果,*表示p<0.05,与对照组比较。由图2可以看出,与对照组相比,不论是注射或是口服给予本保健食品,小鼠肝糖原含量均显著增加,其中,注射给药小、中和大剂量组与对照组差异达显著性水平(图2A),口服给药中和大剂量组与对照组差异达显著水平,具有统计学意义(p<0.05)(图2B),在抗慢性疲劳综合症模型实验中,口服给药小和中剂量组与模型组差异达显著水平(图2C),具有统计学意义(p<0.05)。Figure 2A, Figure 2B, and Figure 2C show the effects of anti-fatigue health food on mice liver glycogen storage, wherein Figure 2A is the first batch of intraperitoneal injection experiment results, * means p<0.05, compared with the control group; Figure 2B is The results of the second batch of oral experiments, * indicates p<0.05, compared with the control group; Figure 2C is the results of the third batch of oral anti-chronic fatigue syndrome experiments, * indicates p<0.05, compared with the control group. It can be seen from Figure 2 that, compared with the control group, no matter whether the health food is given by injection or orally, the liver glycogen content of the mice is significantly increased. reached a significant level (Fig. 2A), and the difference between the oral administration medium and high-dose groups and the control group reached a significant level, which was statistically significant (p<0.05) (Fig. 2B). In the anti-chronic fatigue syndrome model experiment, oral administration The difference between the small and medium dose groups and the model group reached a significant level (Fig. 2C), which was statistically significant (p<0.05).

2.3小鼠全血乳酸测定2.3 Determination of lactic acid in whole blood of mice

图3A、图3B、图3C表示抗疲劳保健食品对小鼠全血乳酸水平的影响。其中图3A为第一批腹腔注射实验结果,*表示p<0.05,与对照组比较;图3B为第二批口服实验结果,C为第三批口服抗慢性疲劳综合症实验结果,**表示p<0.01,与对照组比较。由图3A可以看出,注射给予本保健食品后,与对照组比较,全血乳酸含量明显下降,以中剂量和大剂量最为显著(p<0.05);由图3B可以看出,与对照组相比,口服给予本保健食品后全血乳酸含量均有所下降,但仅大剂量组具统计学意义(p<0.05)。由图3C可以看出,与模型组相比,口服给予本保健食品后大剂量组小鼠全血乳酸含量有明显延长,有统计学显著意义(p<0.01)。Figure 3A, Figure 3B, Figure 3C show the effect of anti-fatigue health food on the level of lactic acid in whole blood of mice. Among them, Figure 3A is the result of the first batch of intraperitoneal injection experiments, * indicates p<0.05, compared with the control group; Figure 3B is the result of the second batch of oral administration, C is the third batch of oral anti-chronic fatigue syndrome experiment results, ** indicates p<0.01, compared with the control group. It can be seen from Figure 3A that after injection of this health food, compared with the control group, the whole blood lactic acid content decreased significantly, and the middle dose and high dose were the most significant (p<0.05); it can be seen from Figure 3B that compared with the control group, In comparison, the whole blood lactic acid content decreased after oral administration of this health food, but only the high dose group had statistical significance (p<0.05). It can be seen from Figure 3C that compared with the model group, the whole blood lactic acid content of the mice in the high-dose group after oral administration of the health food was significantly prolonged, which was statistically significant (p<0.01).

2.4小鼠血浆尿素氮含量测定2.4 Determination of plasma urea nitrogen content in mice

图4A、图4B、图4C、表示抗疲劳保健食品对小鼠血浆尿素氮水平的影响。其中图4A为第一批腹腔注射实验结果,*表示p<0.05,与对照组组比较;图4B为第二批口服实验结果,*表示p<0.05,与对照组组比较;图4C为第三批口服抗慢性疲劳综合症实验结果。由图4可以看出,本保健食品各剂量组血浆尿素氮含量较对照组相比均有所下降。经方差分析注射给药(图4A)中、大剂量组与对照组有高度显著性,口服给药(图4B)大剂量组与对照组有高度显著性(p<0.05),口服给药抗慢性疲劳综合症(图4C)大剂量组与模型组相比有下降趋势,有统计学意义(p<0.05)。Fig. 4A, Fig. 4B, Fig. 4C show the effect of anti-fatigue health food on the plasma urea nitrogen level of mice. Wherein Fig. 4A is the result of the first batch of intraperitoneal injection experiments, * means p<0.05, compared with the control group; Fig. 4B is the result of the second batch of oral experiments, * means p<0.05, compared with the control group; Fig. 4C is the Three batches of oral anti-chronic fatigue syndrome experimental results. It can be seen from Figure 4 that the plasma urea nitrogen content of each dose group of the health food decreased compared with the control group. Through analysis of variance, injection administration (Fig. 4A) middle and large dose groups had a high degree of significance with the control group, oral administration (Fig. 4B) high dose group had a high degree of significance with the control group (p<0.05), oral administration of anti Compared with the model group, chronic fatigue syndrome (Figure 4C) high-dose group had a downward trend, which was statistically significant (p<0.05).

试验表明,腹腔注射给予本发明的这种抗疲劳保健食品具有延长小鼠负重游泳时间的趋势,且此趋势呈剂量依赖性(图1A);与对照组相比,口服给予本发明所述的抗疲劳保健食品混合液后小鼠负重游泳时间呈现剂量依赖性延长,经方差分析,各剂量组与对照组相比有显著性差异(p<0.05)(图1B)。与对照组相比,模型组的小鼠负重游泳时间明显下降,而口服给予所述抗疲劳保健食品后小鼠负重游泳时间与模型组相比有明显延长(图1C)。Tests have shown that intraperitoneal injection of this anti-fatigue health food of the present invention has a tendency to prolong the weight-bearing swimming time of mice, and this trend is dose-dependent (Fig. 1A); After the anti-fatigue health food mixture, the weight-bearing swimming time of the mice was prolonged in a dose-dependent manner. According to variance analysis, there was a significant difference between each dose group and the control group (p<0.05) (Figure 1B). Compared with the control group, the weight-bearing swimming time of the mice in the model group was significantly decreased, and the weight-bearing swimming time of the mice after oral administration of the anti-fatigue health food was significantly prolonged compared with the model group ( FIG. 1C ).

与对照组相比,不论是注射或是口服给予抗疲劳保健食品,小鼠肝糖原含量均显著增加,其中,注射给药小、中和大剂量组与对照组差异达显著性水平(图2A),口服给药中、大剂量组与对照组差异达显著水平(图2B),具有统计学意义(p<0.05),在抗慢性疲劳综合症模型实验中,口服给药大、小剂量组与模型组差异达显著水平(图2C),具有统计学意义(p<0.05)。Compared with the control group, whether the anti-fatigue health food was administered orally, the liver glycogen content of the mice was significantly increased, and the difference between the small, medium and high-dose injection groups and the control group reached a significant level (Fig. 2A), the difference between the oral administration medium and high dose groups and the control group reached a significant level (Figure 2B), which was statistically significant (p<0.05). In the anti-chronic fatigue syndrome model experiment, oral administration of large and small doses The difference between the model group and the model group reached a significant level (Fig. 2C), which was statistically significant (p<0.05).

注射给予抗疲劳保健食品后,与对照组比较,全血乳酸含量明显下降,以中剂量和大剂量最为显著(p<0.05)(图3A);与对照组相比,口服给予抗疲劳 保健食品后全血乳酸含量均有所下降,但只有大剂量组有统计学意义(p<0.05)(图3B)。与模型组相比,口服给予抗疲劳保健食品后小鼠全血乳酸含量有明显延长,有统计学显著意义(p<0.01)(图3C)。After injecting the anti-fatigue health food, compared with the control group, the whole blood lactic acid content decreased significantly, especially in the medium dose and high dose (p<0.05) (Fig. 3A); compared with the control group, the oral administration of the anti-fatigue health food After treatment, the lactate content in whole blood decreased, but only the high-dose group had statistical significance (p<0.05) (Fig. 3B). Compared with the model group, after oral administration of anti-fatigue health food, the lactic acid content in the whole blood of the mice was significantly prolonged, which was statistically significant (p<0.01) (Figure 3C).

本发明的抗疲劳保健食品各剂量组血浆尿素氮含量较对照组相比均有所下降。经方差分析注射给药中、大剂量组与对照组有高度显著性(p<0.05)(图4A),口服给药大剂量组与对照组有高度显著性,口服给药抗慢性疲劳综合症(图4C)大剂量组与模型组相比有下降趋势,有统计学意义(p<0.05)(图4C)。Compared with the control group, the plasma urea nitrogen content of each dose group of the anti-fatigue health food of the present invention has decreased. There is a high significance (p<0.05) (p<0.05) between the injection administration group and the control group through analysis of variance, and the oral administration high-dose group and the control group have a high significance, and the oral administration is anti-chronic fatigue syndrome (Fig. 4C) Compared with the model group, the high-dose group had a downward trend, which was statistically significant (p<0.05) (Fig. 4C).

综合上述实验结果,本发明提供的这种抗疲劳保健食品能明显延长小鼠负重游泳时间、提高疲劳小鼠肝糖原储备、降低疲劳小鼠乳酸和尿素氮含量,提示本发明具有明显的抗疲劳作用。Based on the above experimental results, the anti-fatigue health food provided by the present invention can significantly prolong the weight-bearing swimming time of mice, improve liver glycogen reserves of fatigue mice, and reduce the content of lactic acid and urea nitrogen in fatigue mice, suggesting that the present invention has obvious anti-fatigue effects. Fatigue effect.

这种抗疲劳保健食品的抗疲劳综合症的治疗获得类似效果。The anti-fatigue syndrome treatment of this anti-fatigue health food obtains a similar effect.

根据保健品抗疲劳功能检验方法,延长戊巴比妥钠睡眠时间实验、戊巴比妥钠(或巴比妥钠)阈下剂量催眠实验、戊巴比妥钠睡眠潜伏期实验三项实验中二项阳性,且无明显直接睡眠作用,可判定受试样品抗疲劳功能动物实验结果阳性。以上实验结果说明本保健食品具有抗疲劳功能。According to the anti-fatigue function test method of health products, two of the three experiments were prolonging sleep time of pentobarbital sodium (or barbital sodium) subthreshold dose hypnosis test and pentobarbital sodium sleep latency test. If the item is positive, and there is no obvious direct sleep effect, it can be judged that the anti-fatigue function of the tested sample is positive in animal experiments. The above experimental results show that the health food has anti-fatigue function.

本发明经动物实验证实本保健食品对疲劳有明显的改善作用,具有无毒性,安全,可口服,可食用等优点。Animal experiments of the present invention prove that the health food has obvious improvement effect on fatigue, and has the advantages of non-toxicity, safety, oral administration, edible and the like.

本发明发现本保健食品在抗疲劳的功能检验方法实验中呈阳性,可纠正亚健康状态或治疗慢性疲劳综合症;所述纠正亚健康状态为增加肝糖原含量、减少全血乳酸含量或降低血浆尿素氮含量。动物实验结果表明,具有延长中年与老年小鼠负重游泳时间,增加肝糖原储备,减少乳酸、尿素氮含量,具有用量小、安全、可注射、可口服等优点,具有较大的保健和临床应用价值。本发明 提供的这种抗疲劳功能可应用于制备抗疲劳保健品或食品。The present invention finds that the health food is positive in the anti-fatigue function test method experiment, and can correct the sub-health state or treat chronic fatigue syndrome; the correction of the sub-health state is to increase liver glycogen content, reduce whole blood lactic acid content or reduce Plasma urea nitrogen content. The results of animal experiments show that it can prolong the weight-bearing swimming time of middle-aged and old mice, increase liver glycogen storage, reduce lactic acid and urea nitrogen content, have the advantages of small dosage, safety, injection and oral administration, etc., and have great health care and clinical application value. The anti-fatigue function provided by the invention can be applied to the preparation of anti-fatigue health products or food.

本保健食品抗疲劳的具体研究,对于确认其抗疲劳以及其保健功能有现实意义和应用价值。The specific research on the anti-fatigue of this health food has practical significance and application value for confirming its anti-fatigue and its health care function.

本发明的优点是:The advantages of the present invention are:

1.安全,无毒性,可口服。1. Safe, non-toxic and can be taken orally.

2.对保健食品的功能做了新的探索,在其原知功能基础上做了很好补充,发现其抗疲劳作用。2. Made a new exploration of the function of health food, made a good supplement on the basis of its original function, and found its anti-fatigue effect.

3.本保健食品口服或食用方便,有显著抗疲劳保健功能,推荐人用剂量约为玛咖每天不超25克(60kg.BW),人参每天用量不超过3克(60kg.BW)。3. This health food is convenient to take orally or eat, and has obvious anti-fatigue health care function. The recommended human dosage is about 25 grams (60kg.BW) of maca per day, and no more than 3 grams (60kg.BW) of ginseng per day.

附图说明Description of drawings

图1A为本发明保健食品对小鼠负重游泳时间第一批腹腔注射实验结果柱状图;Fig. 1A is the histogram of the first batch of intraperitoneal injection experiment results of the health food of the present invention on the weight-bearing swimming time of mice;

图1B为本发明保健食品对小鼠负重游泳时间第二批口服实验结果柱状图;Fig. 1B is a histogram of the results of the second batch of oral experiments on the weight-bearing swimming time of mice by the health food of the present invention;

图1C为本发明保健食品对小鼠负重游泳时间第三批口服抗慢性疲劳综合症实验结果柱状图;Fig. 1C is a histogram of the third batch of oral anti-chronic fatigue syndrome experimental results of the health food of the present invention on the weight-bearing swimming time of mice;

图2A为本发明保健食品对小鼠肝糖原储备第一批腹腔注射实验结果柱状图;Fig. 2A is a histogram of the first batch of intraperitoneal injection experiment results of the health food of the present invention on mouse liver glycogen reserve;

图2B为本发明保健食品对小鼠肝糖原储备第二批口服实验结果柱状图;Fig. 2B is a histogram of the results of the second batch of oral administration of the health food of the present invention on mouse liver glycogen reserve;

图2C为本发明保健食品对小鼠肝糖原储备第三批口服抗慢性疲劳综合症实验结果柱状图;Fig. 2C is a histogram of the third batch of oral anti-chronic fatigue syndrome experimental results of the health food of the present invention on mouse liver glycogen reserve;

图3A为本发明保健食品对小鼠全血乳酸水平第一批腹腔注射实验结果柱状图;Fig. 3A is a histogram of the results of the first batch of intraperitoneal injection experiments on the whole blood lactic acid level of mice by the health food of the present invention;

图3B为本发明保健食品对小鼠全血乳酸水平第二批口服实验结果柱状图;Fig. 3B is a histogram of the results of the second batch of oral experiments on the whole blood lactic acid level of mice by the health food of the present invention;

图3C为本发明保健食品对小鼠全血乳酸水平第三批口服抗慢性疲劳综合症实验结果柱状图;Fig. 3C is a histogram of the third batch of oral anti-chronic fatigue syndrome experimental results of the health food of the present invention on the whole blood lactic acid level of mice;

图4A为本发明保健食品对小鼠血浆尿素氮水平的第一批腹腔注射实验结果柱状图;Fig. 4A is a histogram of the first batch of intraperitoneal injection experiment results of the health food of the present invention on the plasma urea nitrogen level in mice;

图4B为本发明保健食品对小鼠血浆尿素氮水平的第二批口服实验结果柱状图;Fig. 4B is a histogram of the results of the second batch of oral experiments on the level of blood urea nitrogen in mice by the health food of the present invention;

图4C为本发明保健食品对小鼠血浆尿素氮水平的第三批口服抗慢性疲劳综合症实验结果柱状图。Fig. 4C is a histogram of the third batch of oral anti-chronic fatigue syndrome test results of the health food of the present invention on the plasma urea nitrogen level of mice.

具体实施方式detailed description

下面结合实施例对本发明作进一步说明。The present invention will be further described below in conjunction with embodiment.

实施例1:Example 1:

一种抗疲劳保健食品,按重量份数配制以下组分:An anti-fatigue health food, the following components are prepared in parts by weight:

玛咖: 30份;Maca: 30 parts;

人参: 12份;Ginseng: 12 parts;

秋葵提取物: 5份;(秋葵提取物:为淡黄色粉末,由黄秋葵的根、叶、花和种子混合、粉碎后提取。主要提取工艺:清水洗净→加开水碎浆→滤除残渣→浓缩干燥。提取物有效成份的浓度为10%)。Okra extract: 5 parts; (okra extract: light yellow powder, extracted after mixing and crushing the roots, leaves, flowers and seeds of okra. Main extraction process: washing with water → adding boiled water to pulverize → filtering Residue → concentrated and dried. The concentration of the active ingredient in the extract is 10%).

黄精: 4份;Polygonatum: 4 parts;

银杏提取物: 1份;(银杏提取物:为浅棕黄色至棕褐色的粉末。是以银杏Ginkgo biloba L.的叶为原料,采用适当的溶剂,提取的有效成分提取物。主要生产工艺流程为:银杏叶→清水洗净等前处理→醇提→回收浓缩→精制→喷雾干燥。提取物有效成份浓度为20%)。Ginkgo biloba extract: 1 part; (Ginkgo biloba extract: light brown to tan powder. The active ingredient extract is extracted from the leaves of Ginkgo biloba L. with an appropriate solvent. The main production process It is: Ginkgo biloba → pretreatment such as washing with water → alcohol extraction → recovery and concentration → refining → spray drying. The concentration of the active ingredient in the extract is 20%).

刺蒺藜提取物: 2份;(刺蒺藜提取物:为棕黄色粉末,主要生产工艺流程为:刺蒺藜原料→粉碎→醇提→浓缩→萃取→干燥。其中皂甙含量为40%)。Tribulus terrestris extract: 2 parts; (Tribulus terrestris extract: brown-yellow powder, the main production process is: Tribulus terrestris raw material→crushing→alcohol extraction→concentration→extraction→drying. Saponin content is 40%).

肉桂提取物: 3份;(肉桂提取物:为黄棕色粉末,主要从樟科植物肉桂 Cinnamomum cassia Presl的树皮中获得的提取物。主要生产工艺流程为:选材→煎煮→渗漉→回流→蒸馏→沉淀→静置→过滤→浓缩→干燥。提取物有效成份含量为15%)。Cinnamon extract: 3 parts; (cinnamon extract: yellow-brown powder, mainly obtained from the bark of Lauraceae Cinnamomum cassia Presl. The main production process is: material selection → decoction → percolation → reflux → Distillation → Precipitation → Standing → Filtration → Concentration → Drying. The active ingredient content of the extract is 15%).

瓜氨酸: 4份;Citrulline: 4 servings;

L-精氨酸 8份L-arginine 8 parts

加2份药用辅料微晶纤维素和1份药用辅料硬脂酸镁,制作为片剂。Add 2 parts of pharmaceutical excipients microcrystalline cellulose and 1 part of pharmaceutical excipients magnesium stearate to make tablets.

然后将原辅料粉碎过筛→预混→制粒干燥→整粒→总混→压片→包衣→内包装→外包→入库。Then crush and sieve the raw materials → premixing → granulation and drying → granulation → total mixing → tabletting → coating → inner packaging → outsourcing → storage.

根据每日1~2次,每次100-2000mg/kg体重的用量,还可以生产为口服液、饮料、胶囊、喷雾剂或透皮吸收剂。According to the dosage of 100-2000mg/kg body weight each time, 1-2 times a day, it can also be produced as oral liquid, beverage, capsule, spray or transdermal absorption agent.

实施例2:Example 2:

一种抗疲劳保健食品,按重量份数配制以下组分:An anti-fatigue health food, the following components are prepared in parts by weight:

玛咖: 35份;Maca: 35 parts;

人参: 16份;Ginseng: 16 parts;

秋葵提取物: 12份;(秋葵提取物:为淡黄色粉末,由黄秋葵的根、叶、花和种子混合、粉碎后提取。主要提取工艺:清水洗净→加开水碎浆→滤除残渣→浓缩干燥。提取物有效成份的浓度为10%)。Okra extract: 12 parts; (okra extract: light yellow powder, extracted after mixing and pulverizing the roots, leaves, flowers and seeds of okra. Main extraction process: washing with water → adding boiling water to pulverize → filtering Residue → concentrated and dried. The concentration of the active ingredient in the extract is 10%).

黄精: 10份;Polygonatum: 10 parts;

银杏提取物: 3份;(银杏提取物:为浅棕黄色至棕褐色的粉末。是以银杏Ginkgo biloba L.的叶为原料,采用适当的溶剂,提取的有效成分提取物。主要生产工艺流程为:银杏叶→清水洗净等前处理→醇提→回收浓缩→精制→ 喷雾干燥。提取物有效成份浓度为20%)。Ginkgo biloba extract: 3 parts; (Ginkgo biloba extract: light brown to tan powder. The active ingredient extract is extracted from the leaves of Ginkgo biloba L. with an appropriate solvent. The main production process It is: Ginkgo biloba leaves → pre-treatment such as washing with water → alcohol extraction → recovery and concentration → refining → spray drying. The concentration of active ingredients in the extract is 20%).

刺蒺藜提取物: 6份;刺蒺藜提取物:2份;(刺蒺藜提取物:为棕黄色粉末,主要生产工艺流程为:刺蒺藜原料→粉碎→醇提→浓缩→萃取→干燥。其中皂甙含量为40%)。Tribulus terrestris extract: 6 parts; Tribulus terrestris extract: 2 parts; (Tribulus terrestris extract: brown yellow powder, the main production process is: Tribulus terrestris raw material→crushing→alcohol extraction→concentration→extraction→drying. Saponin content is 40%).

肉桂提取物: 7份;(肉桂提取物:为黄棕色粉末,主要从樟科植物肉桂Cinnamomum cassia Presl的树皮中获得的提取物。主要生产工艺流程为:选材→煎煮→渗漉→回流→蒸馏→沉淀→静置→过滤→浓缩→干燥。提取物有效成份含量为15%)。Cinnamon extract: 7 parts; (cinnamon extract: yellow-brown powder, mainly obtained from the bark of Lauraceae Cinnamomum cassia Presl. The main production process is: material selection → decoction → percolation → reflux → Distillation → Precipitation → Standing → Filtration → Concentration → Drying. The active ingredient content of the extract is 15%).

瓜氨酸: 9份;Citrulline: 9 servings;

L-精氨酸 10份L-arginine 10 parts

加2份药用辅料微晶纤维素和1份药用辅料硬脂酸镁,制作为片剂。Add 2 parts of pharmaceutical excipients microcrystalline cellulose and 1 part of pharmaceutical excipients magnesium stearate to make tablets.

然后将原辅料粉碎过筛→预混→制粒干燥→整粒→总混→压片→包衣→内包装→外包→入库。Then crush and sieve the raw materials → premixing → granulation and drying → granulation → total mixing → tabletting → coating → inner packaging → outsourcing → storage.

根据每日1~2次,每次100-2000mg/kg体重的用量,还可以生产为口服液、饮料、胶囊、喷雾剂或透皮吸收剂。According to the dosage of 100-2000mg/kg body weight each time, 1-2 times a day, it can also be produced as oral liquid, beverage, capsule, spray or transdermal absorption agent.

实施例3:Example 3:

一种抗疲劳保健食品,按重量份数配制以下组分:An anti-fatigue health food, the following components are prepared in parts by weight:

玛咖: 32份;Maca: 32 parts;

人参: 14份;Ginseng: 14 parts;

秋葵提取物: 10份;(秋葵提取物:为淡黄色粉末,由黄秋葵的根、叶、花和种子混合、粉碎后提取。主要提取工艺:清水洗净→加开水碎浆→滤除残 渣→浓缩干燥。提取物有效成份的浓度为10%)。Okra extract: 10 parts; (okra extract: light yellow powder, extracted after mixing and crushing the roots, leaves, flowers and seeds of okra. Main extraction process: washing with water → adding boiling water to pulverize → filtering Residue → concentrated and dried. The concentration of the active ingredient in the extract is 10%).

黄精: 8份;Polygonatum: 8 parts;

银杏提取物: 2份;(银杏提取物:为浅棕黄色至棕褐色的粉末。是以银杏Ginkgo biloba L.的叶为原料,采用适当的溶剂,提取的有效成分提取物。主要生产工艺流程为:银杏叶→清水洗净等前处理→醇提→回收浓缩→精制→喷雾干燥。提取物有效成份浓度为20%)。Ginkgo biloba extract: 2 parts; (Ginkgo biloba extract: light brown to tan powder. The active ingredient extract is extracted from the leaves of Ginkgo biloba L. with an appropriate solvent. The main production process It is: Ginkgo biloba → pretreatment such as washing with water → alcohol extraction → recovery and concentration → refining → spray drying. The concentration of the active ingredient in the extract is 20%).

刺蒺藜提取物: 5份;(刺蒺藜提取物:为棕黄色粉末,主要生产工艺流程为:刺蒺藜原料→粉碎→醇提→浓缩→萃取→干燥。其中皂甙含量为40%)。Tribulus terrestris extract: 5 parts; (Tribulus terrestris extract: brown-yellow powder, the main production process is: Tribulus terrestris raw material→crushing→alcohol extraction→concentration→extraction→drying. Saponin content is 40%).

肉桂提取物: 5份;(肉桂提取物:为黄棕色粉末,主要从樟科植物肉桂Cinnamomum cassia Presl的树皮中获得的提取物。主要生产工艺流程为:选材→煎煮→渗漉→回流→蒸馏→沉淀→静置→过滤→浓缩→干燥。提取物有效成份含量为15%)。Cinnamon extract: 5 parts; (cinnamon extract: yellow-brown powder, mainly obtained from the bark of Lauraceae Cinnamomum cassia Presl. The main production process is: material selection → decoction → percolation → reflux → Distillation → Precipitation → Standing → Filtration → Concentration → Drying. The active ingredient content of the extract is 15%).

瓜氨酸: 6份;Citrulline: 6 servings;

L-精氨酸 9份L-arginine 9 parts

加2份药用辅料微晶纤维素和1份药用辅料硬脂酸镁,制作为片剂。Add 2 parts of pharmaceutical excipients microcrystalline cellulose and 1 part of pharmaceutical excipients magnesium stearate to make tablets.

然后将原辅料粉碎过筛→预混→制粒干燥→整粒→总混→压片→包衣→内包装→外包→入库。Then crush and sieve the raw materials → premixing → granulation and drying → granulation → total mixing → tabletting → coating → inner packaging → outsourcing → storage.

根据每日1~2次,每次100-2000mg/kg体重的用量,还可以生产为口服液、饮料、胶囊、喷雾剂或透皮吸收剂。According to the dosage of 100-2000mg/kg body weight each time, 1-2 times a day, it can also be produced as oral liquid, beverage, capsule, spray or transdermal absorption agent.

最后需要说明的是,上述描述仅仅为本发明的优选实施例,本领域的普通技术人员在本发明的启示下,在不违背本发明宗旨及权利要求的前提下,可以做出多种类似的表示,这样的变换均落入本发明的保护范围之内。Finally, it should be noted that the above description is only a preferred embodiment of the present invention, and those of ordinary skill in the art can make a variety of similar implementations under the inspiration of the present invention without violating the purpose and claims of the present invention. It means that such transformations all fall within the protection scope of the present invention.

Claims (4)

1.一种抗疲劳保健食品,按重量份数包含以下组分:1. An anti-fatigue health food, comprising the following components in parts by weight: 2.根据权利要求1所述一种抗疲劳保健食品,其特征在于:所述保健食品还添加有药用辅料。2. A kind of anti-fatigue health food according to claim 1, characterized in that: said health food is also added with pharmaceutical excipients. 3.根据权利要求1所述一种抗疲劳保健食品,其特征在于:所述保健食品为口服液、饮料、片剂、胶囊、喷雾剂或透皮吸收剂。3. The anti-fatigue health food according to claim 1, characterized in that: the health food is oral liquid, beverage, tablet, capsule, spray or transdermal absorbent. 4.一种如权利要求1-2所述一种抗疲劳保健食品的制备方法,按如下步骤进行:原辅料粉碎过筛→预混→制粒干燥→整粒→总混→压片→包衣→内包装→外包→入库。4. A preparation method of an anti-fatigue health food as claimed in claim 1-2, which is carried out as follows: raw and auxiliary materials are crushed and sieved → premixed → granulated and dried → granulated → total blended → tabletted → packaged clothing→inner packaging→outsourcing→warehousing.
CN201710253691.XA 2017-04-18 2017-04-18 A kind of fatigue resistant health food and preparation method thereof Pending CN107242563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710253691.XA CN107242563A (en) 2017-04-18 2017-04-18 A kind of fatigue resistant health food and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710253691.XA CN107242563A (en) 2017-04-18 2017-04-18 A kind of fatigue resistant health food and preparation method thereof

Publications (1)

Publication Number Publication Date
CN107242563A true CN107242563A (en) 2017-10-13

Family

ID=60017324

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710253691.XA Pending CN107242563A (en) 2017-04-18 2017-04-18 A kind of fatigue resistant health food and preparation method thereof

Country Status (1)

Country Link
CN (1) CN107242563A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108186699A (en) * 2017-11-19 2018-06-22 山东中医药大学 A kind of traditional Chinese medicine extraction composition dropping pills with anti-fatigue effect and preparation method thereof
CN113951355A (en) * 2021-10-15 2022-01-21 上海舒泽生物科技研究所 Citrulline tablet candy for promoting synthesis of nitric oxide in human body and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (en) * 2011-10-24 2012-02-29 浙江省医学科学院 A kind of Maca compound beverage and preparation method thereof
CN102846693A (en) * 2012-09-13 2013-01-02 北京康比特体育科技股份有限公司 Composition used for relieving exercise-induced fatigue, and preparation method and application thereof
CN102919845A (en) * 2012-11-21 2013-02-13 济南老来寿生物股份有限公司 Health-care food for relieving physical fatigue
CN103169079A (en) * 2013-03-04 2013-06-26 无锡市天赐康生物科技有限公司 Health-care food with anti-fatigue and immunity-enhancing effects, and preparation method thereof
CN104054873A (en) * 2014-07-03 2014-09-24 句容茅宝葛业有限公司 Puerarin polygonatum tea and preparing method thereof
CN104256600A (en) * 2014-09-30 2015-01-07 广州市香雪制药股份有限公司 Health care nutritional composition, preparation method and application thereof
CN104382002A (en) * 2013-08-19 2015-03-04 宣城柏维力生物工程有限公司 Maca tablet for alleviating fatigue

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (en) * 2011-10-24 2012-02-29 浙江省医学科学院 A kind of Maca compound beverage and preparation method thereof
CN102846693A (en) * 2012-09-13 2013-01-02 北京康比特体育科技股份有限公司 Composition used for relieving exercise-induced fatigue, and preparation method and application thereof
CN102919845A (en) * 2012-11-21 2013-02-13 济南老来寿生物股份有限公司 Health-care food for relieving physical fatigue
CN103169079A (en) * 2013-03-04 2013-06-26 无锡市天赐康生物科技有限公司 Health-care food with anti-fatigue and immunity-enhancing effects, and preparation method thereof
CN104382002A (en) * 2013-08-19 2015-03-04 宣城柏维力生物工程有限公司 Maca tablet for alleviating fatigue
CN104054873A (en) * 2014-07-03 2014-09-24 句容茅宝葛业有限公司 Puerarin polygonatum tea and preparing method thereof
CN104256600A (en) * 2014-09-30 2015-01-07 广州市香雪制药股份有限公司 Health care nutritional composition, preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108186699A (en) * 2017-11-19 2018-06-22 山东中医药大学 A kind of traditional Chinese medicine extraction composition dropping pills with anti-fatigue effect and preparation method thereof
CN113951355A (en) * 2021-10-15 2022-01-21 上海舒泽生物科技研究所 Citrulline tablet candy for promoting synthesis of nitric oxide in human body and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103719498B (en) A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof
CN103493941A (en) Weight-reducing and health-protecting tea and preparation method thereof
CN102640822B (en) Health care tea paste and preparation method of health care tea paste
CN102640829B (en) Tea paste with myocardial ischemia function improving function and preparation method of tea paste
CN103859379A (en) Formula and preparation method of life cultivation and health preservation food helpful for improving memory
CN105686006A (en) Oyster compound functional food and preparation method thereof
CN102813779A (en) Novel traditional Chinese medicine composition and preparation method and application thereof
CN105368669A (en) Raw materials for health care wine capable of resisting fatigue and improving immunity and health care wine preparation method
CN102640821B (en) Solid instant health care tea and preparation method of solid instant health care tea
CN103099833A (en) Soft capsule helpful for relieving sports fatigue and delaying aging and preparation method thereof
CN101884783B (en) Wheat bran polypeptide-containing anti-fatigue traditional Chinese medicine and preparation method thereof
CN107048386A (en) A kind of sexual function adjusts health food
CN103610077A (en) Sea cucumber capsule
CN103142848B (en) Anti-aging Chinese medicine preparation and preparation method thereof
CN104489172A (en) Acanthopanax health tea for improving immunity and preparation method thereof
CN103610076A (en) Preparation method for sea cucumber capsule
CN112691179A (en) Traditional Chinese medicine composition for losing weight and preparation method thereof
CN107233491A (en) It is a kind of to improve the antifatigue maca composition of energy
JP2004352626A (en) Anti-cholesterol agent containing plant-derived components
CN108186966A (en) A kind of composition for preventing or improving senile dementia and its application
CN108159191A (en) Composition, purposes and oral liquid of kidney and preparation method thereof are good in establishing-Yang
CN101889683A (en) A kind of health food with anti-fatigue function and preparation method thereof
CN101164603A (en) Compound concentrating matrimony vine capsule and preparation method thereof
CN105582334A (en) Whole-plant healthcare product
CN105815738A (en) A kind of auxiliary hypoglycemic product and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171013

RJ01 Rejection of invention patent application after publication